Evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond

被引：0
|
作者：
Nasrallah, Henry A. [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45267 USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2007年 / 68卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [41] Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study
    Meyer, Jonathan M.
    McEvoy, Joseph P.
    Davis, Vicki G.
    Goff, Donald C.
    Nasrallah, Henry A.
    Davis, Sonia M.
    Hsiao, John K.
    Swartz, Marvin S.
    Stroup, T. Scott
    Lieberman, Jeffrey A.
    BIOLOGICAL PSYCHIATRY, 2009, 66 (11) : 1013 - 1022
  • [42] Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III
    McEvoy, JP
    Meyer, JM
    Goff, DC
    Nasrallah, HA
    Davis, SA
    Sullivan, L
    Meltzer, HY
    Hsiao, J
    Stroup, TS
    Lieberman, JA
    SCHIZOPHRENIA RESEARCH, 2005, 80 (01) : 19 - 32
  • [43] Estimating the optimal dynamic antipsychotic treatment regime: evidence from the sequential multiple-assignment randomized Clinical Antipsychotic Trials of Intervention and Effectiveness schizophrenia study
    Shortreed, Susan M.
    Moodie, Erica E. M.
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2012, 61 : 577 - 599
  • [44] Comparative effectiveness of antipsychotic drugs: Complete results of the CATIE study
    Lieberman, Jeffrey
    Stroup, Scott
    Fleischhacker, W. Wolfgang
    Lewis, Shon
    Swartz, Martin
    Keefe, Richard
    Essock, Susan
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S12 - S12
  • [45] INFLAMMATION, SUBSTANCE USE, SYMPTOMS, AND COGNITION IN PHASE 1 OF THE CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVENESS STUDY
    Miller, Brian
    Buckley, Peter
    McEvoy, Joseph
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S89 - S90
  • [46] Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study
    Miller, Brian J.
    Buckley, Peter F.
    McEvoy, Joseph P.
    SCHIZOPHRENIA RESEARCH, 2018, 195 : 275 - 282
  • [47] Urinary tract infection, inflammation, and cognition in phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study
    Thomas, Joshua
    McEvoy, Joseph P.
    Miller, Brian J.
    ANNALS OF CLINICAL PSYCHIATRY, 2019, 31 (04) : 242 - 248
  • [48] Prevalence of Celiac Disease and Gluten Sensitivity in the United States Clinical Antipsychotic Trials of Intervention Effectiveness Study Population
    Cascella, Nicola G.
    Kryszak, Debra
    Bhatti, Bushra
    Gregory, Patricia
    Kelly, Deanna L.
    Mc Evoy, Joseph P.
    Fasano, Alessio
    Eaton, William W.
    SCHIZOPHRENIA BULLETIN, 2011, 37 (01) : 94 - 100
  • [49] NIMH comparative effectiveness of antipsychotic medications in patients with Alzheimer's disease (CATIE-AD): Clinical course
    Ismail, MS
    Schneider, LS
    Tariot, P
    Dagerman, KS
    Davis, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S188 - S188
  • [50] Beyond clinical trials: The importance of large databases in evaluating differences in the effectiveness of bisphosphonate therapy in postmenopausal osteoporosis
    Lindsay, Robert
    BONE, 2007, 40 (05) : S32 - S35
12345